Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6539771

CCCNC(=O)c1cccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 17/20 0.73
ADRB1 P08588 15/20 0.73
ADRB2 P07550 2/20 0.45
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX2 P34913 1/20 0.42
RAF1 P04049 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6539091 0.93 ADRB3 (0.78) ADRB3ADRB1ADRB2
Trifluoroacetic Acid SCHEMBL6539079 0.91 ADRB3 (0.77) ADRB3ADRB1ADRB2MEN1NPC1
Trifluoroacetic Acid SCHEMBL6538586 0.90 ADRB3 (0.81) ADRB3ADRB1ADRB2MEN1NPC1
SCHEMBL6539775 0.89 ADRB3 (0.59) ADRB3ADRB1MEN1NPC1POLB
Trifluoroacetic Acid SCHEMBL6539591 0.89 ADRB3 (0.91) ADRB3ADRB1ADRB2
Trifluoroacetic Acid SCHEMBL6539548 0.87 ADRB3 (0.76) ADRB3ADRB1ADRB2MEN1NPC1
Trifluoroacetic Acid SCHEMBL6538659 0.86 ADRB3 (0.77) ADRB3ADRB1ADRB2
Trifluoroacetic Acid SCHEMBL6539367 0.86 ADRB3 (0.92) ADRB3ADRB1ADRB2MEN1NPC1
Trifluoroacetic Acid SCHEMBL6538900 0.85 ADRB3 (0.78) ADRB3ADRB1ADRB2MEN1NPC1
SCHEMBL6538488 0.85 ADRB3 (0.80) ADRB3ADRB1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed
WO-2002024635-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-28 WO disclosed